What Should We Expect From PRA Health Sciences, Inc.’s (NASDAQ:PRAH) Earnings In The Years Ahead?

The latest earnings announcement PRA Health Sciences, Inc. (NASDAQ:PRAH) released in December 2018 revealed that the business gained from a large tailwind, eventuating to a high double-digit earnings growth of 77%. Today I want to provide a brief commentary on how market analysts predict PRA Health Sciences’s earnings growth trajectory over the next few years and whether the future looks even brighter than the past. Note that I will be looking at net income excluding extraordinary items to get a better understanding of the underlying drivers of earnings.

View our latest analysis for PRA Health Sciences

Analysts’ expectations for the coming year seems buoyant, with earnings growing by a significant 68%. This high growth in earnings is expected to continue, bringing the bottom line up to US$352m by 2022.

NasdaqGS:PRAH Past and Future Earnings, March 26th 2019
NasdaqGS:PRAH Past and Future Earnings, March 26th 2019

Even though it’s informative knowing the growth each year relative to today’s figure, it may be more valuable to determine the rate at which the business is growing on average every year. The advantage of this technique is that we can get a better picture of the direction of PRA Health Sciences’s earnings trajectory over the long run, irrespective of near term fluctuations, which may be more relevant for long term investors. To compute this rate, I put a line of best fit through the forecasted earnings by market analysts. The slope of this line is the rate of earnings growth, which in this case is 25%. This means that, we can assume PRA Health Sciences will grow its earnings by 25% every year for the next couple of years.

Next Steps:

For PRA Health Sciences, there are three essential aspects you should further research:

  1. Financial Health: Does it have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.
  2. Valuation: What is PRAH worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether PRAH is currently mispriced by the market.
  3. Other High-Growth Alternatives: Are there other high-growth stocks you could be holding instead of PRAH? Explore our interactive list of stocks with large growth potential to get an idea of what else is out there you may be missing!

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.